Technological advances towards extracellular vesicles mass production.

Area of Science:

• Biotechnology
• Regenerative Medicine
• Drug Delivery Systems

Background:

• Extracellular vesicles (EVs) show promise in bio-therapeutics for regenerative and immunomodulatory applications.
• EVs also serve as potential vehicles for targeted drug delivery.
• Current challenges in EV-based therapies include the need for cost-effective, large-scale production.

Purpose of the Study:

• To review advanced techniques for high-yield extracellular vesicle (EV) manufacturing.
• To critically compare different EV production strategies.
• To discuss strategies for mass production of EVs for therapeutic applications.

Main Methods:

• Review of advanced works on high-yield EV manufacturing.
• Comparison of large-scale cell culture platforms.
• Analysis of cell stimulation techniques (physico-chemical stresses, cell membrane disruption) for increased EV yield.
• Discussion of mass production strategies from clinical trials.

Main Results:

• Various approaches exist for high-yield EV manufacturing, including scalable cell culture and cell stimulation methods.
• Cell stimulation can involve moderate physico-chemical stresses or cell membrane disruption to enhance particle yield.
• The field currently lacks standardized characterization methods for EVs.

Conclusions:

• Scalable and cost-effective manufacturing is crucial for the widespread adoption of EV-based therapies.
• Standardization of characterization and assessment of therapeutic potency are essential for clinical translation.
• Exploring and optimizing mass production strategies are key to advancing EV therapeutics.